← New search
Phenotype profile

Duchenne muscular dystrophy

SaudiVarKB evidence summary derived from retained literature mentions.

39Phenotype mentions
39Publications
35Associated gene records
6Associated variant records

Associated gene records

Co-mentioned in the same publications
GeneIdentifier / contextArticlesMentions
COL6A1HGNC:221122
CFTRHGNC:188422
MYH3HGNC:757322
COL1A1HGNC:219711
COL1A2HGNC:219811
SMCHD1HGNC:2909011
DOCK8HGNC:1919111
STAT3HGNC:1136411
PLECHGNC:906911
GAD1HGNC:409211
SLC17A7HGNC:1670411
COL3A1HGNC:220111
LMNAHGNC:663611
PGM3HGNC:890711
GAAHGNC:406511
COL6A3HGNC:221311
SMN1HGNC:1111711
POSTNHGNC:1695311
TIMP1HGNC:1182011
THBS2HGNC:1178611
CAPN3HGNC:148011
SGCAHGNC:1080511
SGCGHGNC:1080911
FBXO32HGNC:1673111
FLNCHGNC:375611
LAMA2HGNC:648211
TTNHGNC:1240311
RYR1HGNC:1048311
VCPHGNC:1266611
ANO5HGNC:2733711
PKP2HGNC:902411
SNTA1HGNC:1116711
SMAD3HGNC:676911
DTNAHGNC:305711
NOS1HGNC:787211

Associated variant records

Co-mentioned in the same publications
VariantIdentifier / contextArticlesMentions
c.1056+1G>Ac.1056+1G>A11
G182AG182A11
R244CR244C11
R244HR244H11
H285YH285Y11
N483SN483S11

Associated population records

Co-mentioned in the same publications
PopulationIdentifier / contextArticlesMentions
Saudi Arabia33
Population recordCohort 1711
Population record11
Population recordCohort 1811
Saudi Arabia · Riyadh11
Saudi ArabiaCohort 22611
Saudi Arabia · RiyadhCohort 1411
Population recordCohort 411
Population recordCohort 3211
Saudi ArabiaCohort 17711
Population recordCohort 7111
Saudi ArabiaCohort 4511
Saudi Arabia · RiyadhCohort 4111

Supporting publications

39 records
  1. 2026Expanding the Potential of Gene Therapy for Duchenne Muscular Dystrophy.Current pharmaceutical design1 mentions
  2. 2026CRISPR Gene Editing for Nucleotide Repeat Expansion Disorders: A Systematic Review of Preclinical and Clinical Evidence.Genetic testing and molecular biomarkers1 mentions
  3. 2026Genetic, Clinical, and Management Characteristics of Duchenne Muscular Dystrophy in Saudi Arabia.Healthcare (Basel, Switzerland)1 mentions
  4. 2026Predictors of quality of life in parents of children with rare diseases: a tertiary care center cross-sectional study in Saudi Arabia.Frontiers in public health1 mentions
  5. 2025A structural genomics approach to investigate Dystrophin mutations and their impact on the molecular pathways of Duchenne muscular dystrophy.Frontiers in genetics1 mentions
  6. 2025A comprehensive spatiotemporal map of dystrophin isoform expression in the developing and adult human brain.Acta neuropathologica communications1 mentions
  7. 2025Unlocking the potential: advancements and applications of gene therapy in severe disorders.Annals of medicine1 mentions
  8. 2025Decoding Myosin-3 mutational hotspots: Linking deleterious variants to Duchenne muscular dystrophy severity and psychiatric comorbidities.PloS one1 mentions
  9. 2025The Utilization, Reimbursement, and Cost of Targeted Therapies for Duchenne Muscular Dystrophy (DMD) in US Medicaid Programs: A Descriptive Trend Analysis from 2017 to 2022.Pharmaceutical medicine1 mentions
  10. 2025Diagnostic Precision in Pediatric Neuromuscular Disorders: A Case Study of Bethlem Myopathy Mimicking Duchenne Muscular Dystrophy.Cureus1 mentions
  11. 2024Discovering Promising Biomarkers and Therapeutic Targets for Duchenne Muscular Dystrophy: a Multiomics Meta-Analysis Approach.Molecular neurobiology1 mentions
  12. 2024A review on mechanistic insights into structure and function of dystrophin protein in pathophysiology and therapeutic targeting of Duchenne muscular dystrophy.International journal of biological macromolecules1 mentions
  13. 2024Exploring lipin1 as a promising therapeutic target for the treatment of Duchenne muscular dystrophy.Journal of translational medicine1 mentions
  14. 2024Duchenne muscular dystrophy in Saudi Arabia: a review of the current literature.Frontiers in neurology1 mentions
  15. 2024Exploring novel natural compound-based therapies for Duchenne muscular dystrophy management: insights from network pharmacology, QSAR modeling, molecular dynamics, and free energy calculations.Frontiers in pharmacology1 mentions
  16. 2024Safety and effectiveness of ataluren in patients with Duchenne muscular dystrophy: single-center experience from Saudi Arabia.The Journal of international medical research1 mentions
  17. 2022Dystrophin Protein Quantification as a Duchenne Muscular Dystrophy Diagnostic Biomarker in Dried Blood Spots Using Multiple Reaction Monitoring Tandem Mass Spectrometry: A Preliminary Study.Molecules (Basel, Switzerland)1 mentions
  18. 2022Association of electrocardiographic markers with myocardial fibrosis as assessed by cardiac magnetic resonance in different clinical settings.World journal of cardiology1 mentions
  19. 2022Gene Therapy for Duchenne Muscular Dystrophy: Unlocking the Opportunities in Countries in the Middle East and Beyond.Journal of neuromuscular diseases1 mentions
  20. 2022Patient demographics and characteristics from an ambispective, observational study of patients with duchenne muscular dystrophy in Saudi Arabia.Frontiers in pediatrics1 mentions
  21. 2021Autism medical comorbidities.World journal of clinical pediatrics1 mentions
  22. 2021Case Report: The Genetic Diagnosis of Duchenne Muscular Dystrophy in the Middle East.Frontiers in pediatrics1 mentions
  23. 2020Meta-analyses of ataluren randomized controlled trials in nonsense mutation Duchenne muscular dystrophy.Journal of comparative effectiveness research1 mentions
  24. 2019Current management of Duchenne muscular dystrophy in the Middle East: expert report.Neurodegenerative disease management1 mentions
  25. 2019Reliability and validity of the turkish translation of pedsqlTM multidimensional Fatigue scale in Duchenne Muscular Dystrophy.Neurosciences (Riyadh, Saudi Arabia)1 mentions
  26. 2018How do physical capacity, fatigue and performance differ in children with duchenne muscular dystrophy compared with their healthy peers?Neurosciences (Riyadh, Saudi Arabia)1 mentions
  27. 2018Pectoralis blocks for insertion of an implantable cardioverter defibrillator in two patients with Duchenne muscular dystrophy.Saudi journal of anaesthesia1 mentions
  28. 2018Molecular characterization of exonic rearrangements and frame shifts in the dystrophin gene in Duchenne muscular dystrophy patients in a Saudi community.Human genomics1 mentions
  29. 2018Carbon nanofiber-based multiplexed immunosensor for the detection of survival motor neuron 1, cystic fibrosis transmembrane conductance regulator and Duchenne Muscular Dystrophy proteins.Biosensors & bioelectronics1 mentions
  30. 2018Multiplexed detection of DOCK8, PGM3 and STAT3 proteins for the diagnosis of Hyper-Immunoglobulin E syndrome using gold nanoparticles-based immunosensor array platform.Biosensors & bioelectronics1 mentions
  31. 2017The sensitivity of exome sequencing in identifying pathogenic mutations for LGMD in the United States.Journal of human genetics1 mentions
  32. 2016Duane retraction syndrome in a patient with Duchenne muscular dystrophy.Ophthalmic genetics1 mentions
  33. 2015Stem Cell Differentiation Toward the Myogenic Lineage for Muscle Tissue Regeneration: A Focus on Muscular Dystrophy.Stem cell reviews and reports1 mentions
  34. 2010Deletion mutations in Duchenne muscular dystrophy (DMD) in Western Saudi children.Saudi journal of biological sciences1 mentions
  35. 2006Drug evaluation: PTC-124--a potential treatment of cystic fibrosis and Duchenne muscular dystrophy.IDrugs : the investigational drugs journal1 mentions
  36. 2002Deletion mutations in the dystrophin gene of Saudi patients with Duchenne and Becker muscular dystrophy.Saudi medical journal1 mentions
  37. 2001In situ measurements of muscle fiber conduction velocity in Duchenne muscular dystrophy.Saudi medical journal1 mentions
  38. 2000Power spectrum analysis and conventional electromyogram in Duchenne muscular dystrophy.Saudi medical journal1 mentions
  39. 1996Clinical and molecular pathological features of severe childhood autosomal recessive muscular dystrophy in Saudi Arabia.Developmental medicine and child neurology1 mentions